{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:11:05Z","timestamp":1793639465979,"version":"4.5.1"},"reference-count":58,"publisher":"Korean Epilepsy Society","issue":"1","content-domain":{"domain":["j-epilepsy.org"],"crossmark-restriction":true},"short-container-title":["J Epilepsy Res"],"DOI":"10.14581\/jer.15001","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T04:25:11Z","timestamp":1435551911000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.14581\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions"],"prefix":"10.14581","volume":"5","author":[{"given":"Arun Kumar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra K.","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5688","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.2174\/1568026053386962","volume-title":"Mechanisms of Action of Antiepileptic Drugs","author":"Czapinski","year":"2005"},{"key":"ref2","volume-title":"Neuropharmacological profile of L-pGlu-(1-benzyl)- L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog: Effects on seizure models, sodium current, cerebral blood flow and behavioural parameters","author":"Rajput","year":"2009"},{"key":"ref3","volume-title":"Alexopoulos. Pharmacoresistant epilepsy: Definition and explanation","author":"Andreas","year":"2013"},{"key":"ref4","volume-title":"Adult Epilepsy","author":"Duncan","year":"2006"},{"key":"ref5","volume-title":"Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood","author":"Arts","year":"2004"},{"key":"ref6","volume-title":"Diagnosing refractory epilepsy: response to sequential treatment schedule","author":"Mohanraj","year":"2006"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1004418","volume-title":"Drug resistant epilepsy","author":"Kwan","year":"2011"},{"key":"ref8","volume-title":"The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs","author":"Stepien","year":"2012"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-6-61","volume-title":"RLIP76, a non-ABC transporter, and drug resistance in epilepsy","author":"Awasthi","year":"2005"},{"key":"ref10","volume-title":"Blood-brain barrier active efflux transporters: ATP binding cassette gene family","author":"Loscher","year":"2005"},{"key":"ref11","volume-title":"Drug resistance in epilepsy: Is the role of underlying pathology related to multidrug resistance protein","author":"Sisodiya","year":"2003"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1124\/mol.104.001966","volume-title":"Regulation of the stability of P-glycoprotein by ubiquitination","author":"Zhang","year":"2004"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1111\/j.0013-9580.2005.31904.x","volume-title":"Potential role of drug transporters in pathogenesis of medically intractable epilepsy","author":"Kwan","year":"2005"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2007.03.011","volume-title":"Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia","author":"Ak","year":"2007"},{"key":"ref15","volume-title":"Expression and cellular distribution of multidrug resistance related proteins in the hippocampus of patients with mesial temporal lobe epilepsy","author":"Aronica","year":"2004"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.2001.12301.x","volume-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","author":"Dombrowski","year":"2001"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2005.11.011","volume-title":"Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis","author":"Kubota","year":"2006"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/S0887-8994(03)00407-7","volume-title":"Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy","author":"Lazarowski","year":"2004"},{"key":"ref19","volume-title":"Drug transporters in the epileptic brain","author":"Losher","year":"2007"},{"key":"ref20","volume-title":"Low-glycaemic-index treatment: a liberalized Ketogenic diet for treatment of intractable epilepsy","author":"Pfeifer","year":"2005"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.3390\/ph3072090","volume-title":"Difficulties in treatment and management of epilepsy and challenges in new drug development","author":"Wahab","year":"2010"},{"key":"ref22","volume-title":"Drug resistance in epilepsy","author":"Czuczwar","year":"2009"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awh682","volume-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","author":"Remy","year":"2006"},{"key":"ref24","volume-title":"New molecular targets for antiepileptic drugs","author":"Rogaswaki","year":"2008"},{"key":"ref25","volume-title":"Epilepsy (generalised)","author":"Muguire","year":"2012"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.2003.02964.x","volume-title":"Rapid and long term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy","author":"Straessle","year":"2003"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200002033420503","volume-title":"Early identification of refractory epilepsy","author":"Kwan","year":"2000"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.2003.01862.x","volume-title":"Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies","author":"Greene","year":"2003"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2013.09.009","volume-title":"Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: a pilot study","author":"Nicita","year":"2014"},{"key":"ref30","volume-title":"Differential effects of atorvastatin treatment and withdrawal on Pentylenetetrazole-induced seizures","author":"Funck","year":"2011"},{"key":"ref31","volume-title":"Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide","author":"Moezi","year":"2012"},{"key":"ref32","volume-title":"Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway","author":"Moazzami","year":"2013"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2008.05.112","volume-title":"Statin inhibits kainic acid induced seizure and associated inflammation and hippocampal cell death","author":"Lee","year":"2008"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2012.09.004","volume-title":"Neuropeptide Y and its role in CNS disease and repair","author":"Decressac","year":"2012"},{"key":"ref35","volume-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibres in patients with temporal lobe epilepsy","author":"Furtinger","year":"2001"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.43.s.5.2.x","volume-title":"Altered expression of neuropeptide Y, -Y (1), and -Y (2) receptors in the hippocampus of patients with mesial temporal lobe epilepsy","author":"Furtinger","year":"2002"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2011.07612.x","volume-title":"Seizure-induced neurogenesis in the adult brain","author":"Kokaia","year":"2011"},{"key":"ref38","volume-title":"Over expression of multidrug resistance associated protein-2 in the brain of Pentylenetetrazole Kindled Rats","author":"Yao","year":"2012"},{"key":"ref39","volume-title":"Anti-epileptic effects of neuropeptide Y gene transfection into the rat brain","author":"Dong","year":"2013"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.2003.03603.x","volume-title":"Seizure Suppression by Adenosine A1 Receptor Activation in a mouse Model of Pharmacoresistant Epilepsy","author":"Gouder","year":"2003"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.1016\/S0920-1211(00)00178-9","volume-title":"Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents","author":"Jaworska-Feil","year":"2001"},{"key":"ref42","volume-title":"Protective effects of TRH and its analogues in chemical and genetic models of seizures","author":"Przew\u0142ocka","year":"1997"},{"key":"ref43","volume-title":"Modulating P-Glycoprotein Regulation: Future perspectives for Pharmacoresistant Epilepsies","author":"Potschka","year":"2010"},{"key":"ref44","volume-title":"Thyrotropin-releasing hormone in the treatment of intractable epilepsy. Pediatr","author":"Kubek","year":"2002"},{"key":"ref45","volume-title":"Thyrotropin-releasing hormone increases GABA release in rat hippocampus","author":"Deng","year":"2007"},{"key":"ref46","volume-title":"Pharmacoresistant epilepsy: From pathogenesis to current and emerging therapies","author":"Pati","year":"2010"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.4137\/JCNSD.S8315","volume-title":"Pharmacotherapeutic and non-pharmacological options for refractory and difficult-to-treat seizures","author":"Mitchell","year":"2012"},{"key":"ref48","volume-title":"Vagus nerve stimulation","author":"Schachter","year":"1998"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2010.02536.x","volume-title":"Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy","author":"Fisher","year":"2010"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2005.00299.x","volume-title":"Transcortical cooling inhibits hippocampal-kindled seizures in the rat","author":"Burton","year":"2005"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.2002.40101.x","volume-title":"Cooling abolishes neuronal network synchronization in rat hippocampal slices","author":"Javedan","year":"2002"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.1111\/j.0013-9580.2003.23003.x","volume-title":"Long-lasting anticonvulsant effect of focal cooling on experimental neocortical seizures","author":"Yang","year":"2003"},{"key":"ref53","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.2003.55502.x","volume-title":"Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo","author":"Bough","year":"2003"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2011.01.003","volume-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","author":"Loscher","year":"2011"},{"key":"ref55","volume-title":"The Ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","author":"Neal","year":"2008"},{"key":"ref56","volume-title":"Ketogenic diets in the treatment of epilepsy: short-term clinical effects","author":"Schwartz","year":"1989"},{"key":"ref57","volume-title":"Botanicals and herbs: a traditional approach to treating epilepsy","author":"Schachter","year":"2009"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.3390\/ph3051426","volume-title":"Natural products in epilepsy-the present situation and perspectives for the future","author":"Ekstein","year":"2010"}],"container-title":["Journal of Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.j-epilepsy.org\/upload\/er-5-1-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T16:53:49Z","timestamp":1652633629000},"score":1,"resource":{"primary":{"URL":"http:\/\/j-epilepsy.org\/journal\/view.php?doi=10.14581\/jer.15001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.14581\/jer.15001","relation":{},"ISSN":["2233-6249","2233-6257"],"issn-type":[{"value":"2233-6249","type":"print"},{"value":"2233-6257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]},"assertion":[{"value":"2015-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-06-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}